Corcept Therapeutics Inc. buy Truist Financial Co.
Start price
04.06.24
/
50%
€30.31
Target price
04.06.25
€59.79
Performance (%)
5.28%
Price
02.09.24
€31.91
Summary
This prediction is currently active. With a performance of 5.28%, the BUY prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc. is trending in the right direction. This prediction currently runs until 04.06.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Corcept Therapeutics Inc. | 2.935% | 2.935% |
iShares Core DAX® | -1.414% | 7.218% |
iShares Nasdaq 100 | -2.316% | 4.450% |
iShares Nikkei 225® | -2.756% | 10.071% |
iShares S&P 500 | -1.849% | 4.760% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $65.00 price target on the stock, up previously from $44.00.
Ratings data for CORT provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.62
17.06.24
17.06.24
€60.58
17.06.25
17.06.25
19.87%
02.09.24
02.09.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.88
02.05.24
02.05.24
€41.15
02.05.25
02.05.25
39.47%
02.09.24
02.09.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.60
16.02.24
16.02.24
€39.06
16.02.25
16.02.25
41.19%
02.09.24
02.09.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.00
06.11.23
06.11.23
€35.38
06.11.24
06.11.24
32.96%
02.09.24
02.09.24